C247 - What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
| Event Time: | Friday May 10, 2019 7:00 am to 9:00 am |
| Topic(s): | Headache, Neurohospitalist, Foundations in Clinical Neurology for APPs |
| Director(s): | Stephanie Nahas MD, FAAN |
| Description: | Through a combined case-based and didactic approach with audience participation faculty will illustrate empiric and evidence-based diagnosis and management strategies for patients presenting with headache in the urgent or inpatient setting. Topics will include migraine, trigeminal autonomic cephalalgias, and secondary headaches. Three or four illustrative cases will serve as the backbone of this course, with one faculty member leading each case discussion, but all participating as part of a panel. |
| Completion Message: | Participants should be able to discuss the diagnostic approach to patients with headache in the emergency department or hospital and explain the process and rationale for selecting therapy. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Systems-Based Practice |
| Start/End Time | Title | Faculty |
|---|---|---|
| 7:00 AM - 7:05 AM | Introduction | Stephanie J. Nahas MD, FAAN |
| 7:05 AM - 8:45 AM | Case Discussions | Clinton G. Lauritsen MD, Stephanie J. Nahas MD, FAAN, William B. Young MD, FAAN |
| 8:45 AM - 9:00 AM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Clinton G. Lauritsen, MD | Dr. Lauritsen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Biohaven, Cefaly. |
| Stephanie J. Nahas, MD, FAAN | Dr. Nahas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen/Novartis, Biohaven, electroCore, Eli Lilly, Supernus, Teva, Theranica, and Zosano. |
| William B. Young, MD, FAAN | Dr. Young has received personal compensation for consulting, serving on a scientific advisory board speaking or other activities with Alder Allergan Amgen Biohaven Lilly Promius Teva. Dr. Young has received research support from Amgen Autonomic Technology Colucid Cumberland Dr. Reddy Laboratories Eli Lilly Novartis PCORI Scion Teva and Zosano. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C249 -
Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems
S. Josephson MD, FAAN |
| 11:45 AM-12:45 PM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
S59 -
Migraine: Impact, Treatment Patterns and Resource Utilization
|